It has been a story that has had many people sitting in utter disgust. EpiPen maker Mylan has been under scrutiny for raising the prices of their life saving allergy medication. The price increase was so outrageous that Mylan CEO Heather Bresh had to testify before the House Oversight and Government Reform Committee because of … Continue reading “EpiPen Maker Mylan Has Been Abusing Our Tax Money”
Biotech & Pharma
Could This Cancer Drug Help Alzheimer’s Patients?
The Alzheimer's Drug Discovery Foundation (ADDF) has just awarded a $2.1 million grant to R.…
Allergan (AGN) May Pay A Lot Of Money For This Company
Pharmaeutical titan, Allergan, is acquiring Tobira Therapuetics in a deal that's initially for $28.35 per…
New Cancer Drug Gives Hope To Many
A small trial has given hope to cancer fighters, especially those with the deadly form…
Merck & Co.(MRK) Just Discontinued This Major Pipeline Drug
Merck & Co. Inc. made a big announcement over its osteoporosis pipeline drug, odanacatib. The…
Mylan (MYL) To Make Cheaper Version Of EpiPen
It seems like Mylan NV has been paying attention to all the backlash against it…
Mylan’s (MYL) Price Of Epi Pens Just Got Cut In Half
EpiPens cost a lot of money but Mylan Pharamceuticals, the company who manufactures them, just…
Pfizer (PFE) In Talks To Acquire This Major Company
Sources familiar with the situation have revealed on Sunday that Pfizer Inc. is in advanced…
Medivation (MDNV) Gets Interest From Major Pharma
Medivation shares soared higher on Wednesday when a report revealed that at least five pharmaceutical…
Why Is Valeant (VRX) Under Criminal Investigation?
According to sources that told the Wall Street Journal what they knew, Valeant Pharmaceuticals may…
Heron (HRTX) Gets Green Light From FDA
Heron Therapeutic Inc's long acting injection Sustol, to prevent chemotherapy induced nausea and vomiting had…
New Vaccine Could Help Cocaine Addicts
Cocaine is one hell of a drug and for the more than 2 million people…
MEI Pharma Just Landed A Huge Million Dollar Deal
MEI Pharma will be getting $20 million in near-term cash and potentially hundreds millions more…
Ionis Pharmaceuticals (IONS) Achieves Major Milestone
Ionis shares saw a big pop in pre market trading on Monday, rising 37% to…
